Cargando…
Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151945/ https://www.ncbi.nlm.nih.gov/pubmed/34065816 http://dx.doi.org/10.3390/healthcare9050569 |
_version_ | 1783698503489290240 |
---|---|
author | Ansa, Benjamin E. Lewis, Nicollette Hoffman, Zachary Datta, Biplab Johnson, J. Aaron |
author_facet | Ansa, Benjamin E. Lewis, Nicollette Hoffman, Zachary Datta, Biplab Johnson, J. Aaron |
author_sort | Ansa, Benjamin E. |
collection | PubMed |
description | Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy and implementing programs for CRC prevention and control. This study examines the trends and sociodemographic factors associated with blood stool test utilization (BSTU) for CRC screening in Georgia, USA. The Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for Average Annual Percent Change (AAPC) in BSTU between 1997 and 2014 among adults aged 50+ who have had a blood stool test within the past two years, and logistic regression analysis of the 2016 data was performed to identify the associated sociodemographic factors. In Georgia, an overall decrease was observed in BSTU, from 27.8% in 1997 to 16.1% in 2014 (AAPC = −2.6, p = 0.023). The decrease in BSTU was less pronounced in Georgia than nationally (from 26.1% in 1997 to 12.8% in 2014 (AAPC = −4.5, p < 0.001)). BSTU was significantly associated with black race/ethnicity (Black vs. White (aOR = 1.43, p = 0.015)), older age (≥70 vs. 50–59 (aOR = 1.62, p = 0.006)), having insurance coverage (no vs. yes (aOR = 0.37 p = 0.005)), and lower income (≥USD 50,000 vs. <USD 25,000 (aOR = 0.70 p = 0.050)). These findings reveal a decrease over time in BSTU in Georgia, with existing differences between sociodemographic groups. Understanding these patterns helps in directing tailored programs for promoting CRC screening, especially among disadvantaged populations. |
format | Online Article Text |
id | pubmed-8151945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81519452021-05-27 Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA Ansa, Benjamin E. Lewis, Nicollette Hoffman, Zachary Datta, Biplab Johnson, J. Aaron Healthcare (Basel) Article Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy and implementing programs for CRC prevention and control. This study examines the trends and sociodemographic factors associated with blood stool test utilization (BSTU) for CRC screening in Georgia, USA. The Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for Average Annual Percent Change (AAPC) in BSTU between 1997 and 2014 among adults aged 50+ who have had a blood stool test within the past two years, and logistic regression analysis of the 2016 data was performed to identify the associated sociodemographic factors. In Georgia, an overall decrease was observed in BSTU, from 27.8% in 1997 to 16.1% in 2014 (AAPC = −2.6, p = 0.023). The decrease in BSTU was less pronounced in Georgia than nationally (from 26.1% in 1997 to 12.8% in 2014 (AAPC = −4.5, p < 0.001)). BSTU was significantly associated with black race/ethnicity (Black vs. White (aOR = 1.43, p = 0.015)), older age (≥70 vs. 50–59 (aOR = 1.62, p = 0.006)), having insurance coverage (no vs. yes (aOR = 0.37 p = 0.005)), and lower income (≥USD 50,000 vs. <USD 25,000 (aOR = 0.70 p = 0.050)). These findings reveal a decrease over time in BSTU in Georgia, with existing differences between sociodemographic groups. Understanding these patterns helps in directing tailored programs for promoting CRC screening, especially among disadvantaged populations. MDPI 2021-05-12 /pmc/articles/PMC8151945/ /pubmed/34065816 http://dx.doi.org/10.3390/healthcare9050569 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ansa, Benjamin E. Lewis, Nicollette Hoffman, Zachary Datta, Biplab Johnson, J. Aaron Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title | Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title_full | Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title_fullStr | Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title_full_unstemmed | Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title_short | Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA |
title_sort | evaluation of blood stool test utilization for colorectal cancer screening in georgia, usa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151945/ https://www.ncbi.nlm.nih.gov/pubmed/34065816 http://dx.doi.org/10.3390/healthcare9050569 |
work_keys_str_mv | AT ansabenjamine evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa AT lewisnicollette evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa AT hoffmanzachary evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa AT dattabiplab evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa AT johnsonjaaron evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa |